Exdensur approved in EU for severe asthma and CRSwNP
18th February 2026 Uncategorised 0
European Commission backs first ultra‑long‑acting biologic for respiratory disease

More: Exdensur approved in EU for severe asthma and CRSwNP
Source: News
European Commission backs first ultra‑long‑acting biologic for respiratory disease

More: Exdensur approved in EU for severe asthma and CRSwNP
Source: News
© 1994 - 2026 B.M. Pharmaceuticals